These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 3125957)

  • 21. Osteosarcoma of the limb: an institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery.
    Postma A; Kamps WA; Schraffordt Koops H; Veth RP; Göeken LN; Molenaar WM
    Cancer Treat Res; 1993; 62():361-4. PubMed ID: 7682095
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long-term follow-up results after heavy dose chemotherapy of primary malignant bone tumors of the limbs].
    Cui TH
    Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):307-10. PubMed ID: 8174471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local control and survival from the Cooperative Osteosarcoma Study Group studies of the German Society of Pediatric Oncology and the Vienna Bone Tumor Registry.
    Winkler K; Bieling P; Bielack S; Delling G; Dose C; Jürgens H; Kotz R; Ritter J; Salzer-Kuntschik M
    Clin Orthop Relat Res; 1991 Sep; (270):79-86. PubMed ID: 1715820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].
    Boussen H; Mezzi F; Gamoudi A; Daldoul O; Ben Hamida H; Mezlini A; Khalfallah S; Karray S; Ben Romdhane K; Ben Ghachem M; Ben Abdallah M; Douik M; Saadi A; Ben Ayed F; Ben Hassine H
    Bull Cancer; 2000 Feb; 87(2):183-8. PubMed ID: 10705289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.
    Tsuchiya H; Tomita K; Mori Y; Asada N; Morinaga T; Kitano S; Yamamoto N
    Anticancer Res; 1998; 18(1B):657-66. PubMed ID: 9584049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin.
    Bacci G; Picci P; Ruggieri P; Mercuri M; Avella M; Capanna R; Brach Del Prever A; Mancini A; Gherlinzoni F; Padovani G
    Cancer; 1990 Jun; 65(11):2539-53. PubMed ID: 2337871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk-Based Therapy for Localized Osteosarcoma.
    Venkatramani R; Murray J; Helman L; Meyer W; Hicks MJ; Krance R; Lau C; Jo E; Chintagumpala M
    Pediatr Blood Cancer; 2016 Mar; 63(3):412-7. PubMed ID: 26501936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
    Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
    Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patients.
    Tunn PU; Reichardt P
    Onkologie; 2007 May; 30(5):228-32. PubMed ID: 17460416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy?
    Bacci G; Picci P; Gherlinzoni F; Van Horn JR; Orlandi M; Normand AR; Manfrini M; Pignatti G; Campanacci M
    Chemioterapia; 1986 Apr; 5(2):140-3. PubMed ID: 3458546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of various aspects of surgical management to outcome in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group.
    Makley JT; Krailo M; Ertel IJ; Fryer CJ; Baum ES; Weetman RM; Yunis EJ; Bleyer WA; Hammond GD
    J Pediatr Surg; 1988 Feb; 23(2):146-51. PubMed ID: 3422682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.
    Ferrari S; Ruggieri P; Cefalo G; Tamburini A; Capanna R; Fagioli F; Comandone A; Bertulli R; Bisogno G; Palmerini E; Alberghini M; Parafioriti A; Linari A; Picci P; Bacci G
    J Clin Oncol; 2012 Jun; 30(17):2112-8. PubMed ID: 22564997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of preoperative radiotherapy in nonmetastatic high-grade osteosarcoma of the extremities for limb-sparing surgery.
    Dinçbaş FO; Koca S; Mandel NM; Hiz M; Dervişoğlu S; Seçmezacar H; Oksüz DC; Ceylaner B; Uzel B
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):820-8. PubMed ID: 15936566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience of the EORTC Radiotherapy/Chemotherapy Group in osteosarcoma trials.
    Burgers JM
    Cancer Treat Res; 1993; 62():173-5. PubMed ID: 8096730
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A monocentric therapy study: an approach to optimize the results of the treatment of osteosarcoma by protocols based upon HDMTX, associated with systematic conservative surgery.
    Delepine N; Delepine G; Desbois JC
    Cancer Treat Res; 1993; 62():327-32. PubMed ID: 7682092
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.
    Link MP; Goorin AM; Miser AW; Green AA; Pratt CB; Belasco JB; Pritchard J; Malpas JS; Baker AR; Kirkpatrick JA
    N Engl J Med; 1986 Jun; 314(25):1600-6. PubMed ID: 3520317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.
    Ihde DC; Deisseroth AB; Lichter AS; Bunn PA; Carney DN; Cohen MH; Veach SR; Makuch RW; Johnston-Early A; Abrams RA
    J Clin Oncol; 1986 Oct; 4(10):1443-54. PubMed ID: 3020181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adjuvant chemotherapy of osteosarcoma].
    Yamawaki S; Isu K; Ubayama Y; Takeda N; Yagi T; Usui M; Isii S
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):180-8. PubMed ID: 2301948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
    Tabone MD; Kalifa C; Rodary C; Raquin M; Valteau-Couanet D; Lemerle J
    J Clin Oncol; 1994 Dec; 12(12):2614-20. PubMed ID: 7989936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.